Rifaximin works by inhibiting bacteria from making proteins they need to grow and survive. This causes the bacteria to die or lose their ability to function. It is not effective against viruses, such as the cold or flu. It is also not useful against sexually transmitted infections or other types of bacterial infections.
Despite advances in the management of chronic liver disease, infection-related morbidity and mortality continue to increase worldwide. Bacterial resistance to antibiotics is a significant contributing factor in the progression of chronic liver disease, including cirrhosis. Consequently, the development of alternative therapeutic options is important.
Start your review of Innovative Rifaximin Manufacturer | Redefining Gastrointestinal Treatment.